Theriva Biologics Inc (FRA:SFY)
€ 0.227 -0.009 (-3.81%) Market Cap: 3.99 Mil Enterprise Value: -8.48 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 33/100

Q3 2023 Theriva Biologics Inc Earnings Call Transcript

Nov 13, 2023 / 01:30PM GMT
Operator

Greetings, and welcome to the Theriva biologics, Inc. 2023 third quarter operational highlights and financial results. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Steve Shallcross. Thank you. You may begin.

Steven A. Shallcross
Theriva Biologics, Inc. - CEO, CFO & Director

Thank you, Erin, and good morning, everyone, and thank you for joining our call today. Welcome to Theriva Biologics third-quarter 2023 investor conference call. Joining me on today's call will be Dr. Manel Cascall�, Director General of Theriva Biologics European subsidiary, and Dr. Vince Wacher, Head of Corporate and Product Development of Theriva Biologics.

Theriva Biologics issued a press release this morning, which provided operational highlights and included the financial results for the third quarter ended September 30, 2023. The press release can be found in the Investors section of the company website at www.therivabio.com,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot